Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutical Research is Scopus-indexed (Q1, CiteScore 8.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 0724-8741Verify ISSN ↗1573-904XVerify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,690 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 30 / 278 | 89th | Q1 |
| Organic Chemistry | 32 / 215 | 85th | Q1 |
| Pharmacology | 49 / 328 | 85th | Q1 |
| Pharmaceutical Science | 32 / 191 | 83rd | Q1 |
| Biotechnology | 71 / 325 | 78th | Q1 |
| Molecular Medicine | 42 / 179 | 76th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q1, CiteScore 8.7.
Pharmaceutical Research is Q1 in Pharmacology (medical) (rank 30 of 278), Q1 in Organic Chemistry (rank 32 of 215) and Q1 in Pharmacology (rank 49 of 328), by CiteScore 2025. It is ranked in 6 subject areas in all.
Pharmaceutical Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.7, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.873, quartile Q1, with an H-index of 241.
The publisher lists an article processing charge of about US$4,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmaceutical Research is published by Springer. Its print ISSN is 0724-8741 and its online ISSN is 1573-904X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmaceutical Research has an h-index of 265 and a 2-year mean of 3.81 citations per paper (OpenAlex). Its Scopus CiteScore is 8.7, quartile Q1. On 2-year citations it ranks #57 of 271 Scopus journals in Pharmacology (medical).
Pharmaceutical Research published 189 papers in 2025; its busiest recent year was 2022 with 305. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from United States (33%), China (21.7%) and India (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 24 retracted papers are recorded (2.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.